Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hematology
Volume 2015, Article ID 583451, 3 pages
http://dx.doi.org/10.1155/2015/583451
Case Report

Severe Refractory Immune Thrombocytopenia Successfully Treated with High-Dose Pulse Cyclophosphamide and Eltrombopag

1Department of Medicine, University of Arizona, Tucson, AZ 86721, USA
2Medical Oncology, Arizona Oncology Associates, Tucson, AZ 85704, USA
3Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, WA 98109, USA

Received 11 March 2015; Accepted 3 June 2015

Academic Editor: Tatsuharu Ohno

Copyright © 2015 Faiz Anwer et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Stasi, M. L. Evangelista, E. Stipa, F. Buccisano, A. Venditti, and S. Amadori, “Idiopathic thrombocytopenic purpura: current concepts in pathophysiology and management,” Thrombosis and Haemostasis, vol. 99, no. 1, pp. 4–13, 2008. View at Publisher · View at Google Scholar
  2. D. B. Cines, J. B. Bussel, H. A. Liebman, and E. T. Luning Prak, “The ITP syndrome: pathogenic and clinical diversity,” Blood, vol. 113, no. 26, pp. 6511–6521, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. R. McMillan, G. A. Luiken, R. Levy, R. Yelenosky, and R. L. Longmire, “Antibody against megakaryocytes in idiopathic thrombocytopenic purpura,” The Journal of the American Medical Association, vol. 239, no. 23, pp. 2460–2462, 1978. View at Publisher · View at Google Scholar
  4. J. C. Andersen, “Response of resistant idiopathic thrombocytopenic purpura to pulsed high-dose dexamethasone therapy,” The New England Journal of Medicine, vol. 330, no. 22, pp. 1560–1564, 1994. View at Publisher · View at Google Scholar
  5. D. M. Arnold, I. Nazi, A. Santos et al., “Combination immunosuppressant therapy for patients with chronic refractory immune thrombocytopenic purpura,” Blood, vol. 115, no. 1, pp. 29–31, 2010. View at Google Scholar
  6. U. Abad, O. Yarchovsky-Dolberg, and M. H. Ellis, “Immune thrombocytopenia: recent progress in pathophysiology and treatment,” Clinical and Applied Thrombosis/Hemostasis, vol. 21, no. 5, pp. 397–404, 2015. View at Publisher · View at Google Scholar
  7. D. B. Cines and J. B. Bussel, “How I treat idiopathic thrombocytopenic purpura (ITP),” Blood, vol. 106, no. 7, pp. 2244–2251, 2005. View at Publisher · View at Google Scholar
  8. R. McMillan and C. Durette, “Long-term outcomes in adults with chronic ITP after splenectomy failure,” Blood, vol. 104, no. 4, pp. 956–960, 2004. View at Google Scholar
  9. Cangene Corporation, Rho(D) Immune Globulin Intravenous (Human): WinRhoSDF, Cangene Corporation, Winnipeg, Canada, 2004.
  10. K. Abderrahim, N. Benromdhan, A. Waage et al., “Rituximab as second line treatment for adult immune thrombocytopenia (ITP): a multicenter randomized, double blind, placebo-controlled study—the Ritp study (NCT00344149),” Blood, vol. 122, no. 21, p. 449, 2013. View at Google Scholar
  11. S. Song, A. R. Crow, J. Freedman, and A. H. Lazarus, “Monoclonal IgG can ameliorate immune thrombocytopenia in a murine model of ITP: an alternative to IVIG,” Blood, vol. 101, no. 9, pp. 3708–3713, 2003. View at Publisher · View at Google Scholar
  12. M. E. Bromberg, “Immune thrombocytopenic purpura—the changing therapeutic landscape,” The New England Journal of Medicine, vol. 355, no. 16, pp. 1643–1645, 2006. View at Publisher · View at Google Scholar
  13. D. Gomez-Almaguer, M. A. Herrera-Rojas, A. Gomez-de Leon et al., “Eltrombopag and high-dose dexamethasone as first line treatment for ITP,” Blood, vol. 122, no. 21, p. 3544, 2013. View at Google Scholar
  14. D. M. Boruchov, S. Gururangan, M. C. Driscoll, and J. B. Bussel, “Multiagent induction and maintenance therapy for patients with refractory immune thrombocytopenic purpura (ITP),” Blood, vol. 110, no. 10, pp. 3526–3531, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. G. Emilia, M. Morselli, M. Luppi et al., “Long-term salvage therapy with cyclosporin A in refractory idiopathic thrombocytopenic purpura,” Blood, vol. 99, no. 4, pp. 1482–1485, 2002. View at Publisher · View at Google Scholar
  16. A. R. Crow, S. Song, S. J. Suppa et al., “Amelioration of murine immune thrombocytopenia by CD44 antibodies: a potential therapy for ITP?” Blood, vol. 117, no. 3, pp. 971–974, 2011. View at Publisher · View at Google Scholar
  17. A. Solanilla, J. M. Pasquet, J. F. Viallard et al., “Platelet-associated CD154 in immune thrombocytopenic purpura,” Blood, vol. 105, no. 1, pp. 215–218, 2005. View at Google Scholar
  18. A. Tyndall, J. Passweg, and A. Gratwohl, “Haemopoietic stem cell transplantation in the treatment of severe autoimmune diseases 2000,” Annals of the Rheumatic Diseases, vol. 60, no. 7, pp. 702–707, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Gratwohl, J. Passweg, C. Bocelli-Tyndall et al., “Autologous hematopoietic stem cell transplantation for autoimmune diseases,” Bone Marrow Transplantation, vol. 35, no. 9, pp. 869–879, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. R. C. Skoda, A. Tichelli, A. Tyndall, T. Hoffmann, S. Gillessen, and A. Gratwohl, “Autologous peripheral blood stem cell transplantation in a patient with chronic autoimmune thrombocytopenia,” British Journal of Haematology, vol. 99, no. 1, pp. 56–57, 1997. View at Publisher · View at Google Scholar · View at Scopus
  21. A. R. Zander, S. Culbert, S. Jagannath et al., “High dose cyclophosphamide, BCNU, and VP-16 (CBV) as a conditioning regimen for allogeneic bone marrow transplantation for patients with acute leukemia,” Cancer, vol. 59, no. 6, pp. 1083–1086, 1987. View at Publisher · View at Google Scholar
  22. R. D. Huhn, P. F. Fogarty, R. Nakamura et al., “High-dose cyclophosphamide with autologous lymphocyte-depleted peripheral blood stem cell (PBSC) support for treatment of refractory chronic autoimmune thrombocytopenia,” Blood, vol. 101, no. 1, pp. 71–77, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. L. Luznik, J. Bolaños-Meade, M. Zahurak et al., “High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease,” Blood, vol. 115, no. 16, pp. 3224–3230, 2010. View at Publisher · View at Google Scholar
  24. R. A. Brodsky, A. R. Che, D. Dorr et al., “High-dose cyclophosphamide for severe aplastic anemia: long-term follow-up,” Blood, vol. 115, no. 11, pp. 2136–2141, 2010. View at Publisher · View at Google Scholar
  25. V. M. Moyo, D. Smith, I. Brodsky, P. Crilley, R. J. Jones, and R. A. Brodsky, “High-dose cyclophosphamide for refractory autoimmune hemolytic anemia,” Blood, vol. 100, no. 2, pp. 704–706, 2002. View at Google Scholar
  26. R. A. Brodsky, M. Petri, B. D. Smith et al., “Immunoablative high-dose cyclophosphamide without stem-cell rescue for refractory, severe autoimmune disease,” Annals of Internal Medicine, vol. 129, no. 12, pp. 1031–1035, 1998. View at Publisher · View at Google Scholar
  27. A. Reiner, T. Gernsheimer, and S. J. Slichter, “Pulse cyclophosphamide therapy for refractory autoimmune thrombocytopenic purpura,” Blood, vol. 85, no. 2, pp. 351–358, 1995. View at Google Scholar · View at Scopus
  28. R. Stasi, E. Rhodes, R. Benjamin et al., “The emergence of thrombopoietin receptor agonists as a novel treatment for immune thrombocytopenia,” European Oncology & Haematology, vol. 7, no. 1, pp. 63–70, 2011. View at Google Scholar
  29. N. Cooper, I. Terrinoni, and A. Newland, “The efficacy and safety of romiplostim in adult patients with chronic immune thrombocytopenia,” Therapeutic Advances in Hematology, vol. 3, no. 5, pp. 291–298, 2012. View at Publisher · View at Google Scholar
  30. S. K. Vesely, J. J. Perdue, M. A. Rizvi, D. R. Terrell, and J. N. George, “Management of adult patients with persistent idiopathic thrombocytopenic purpura following splenectomy: a systematic review,” Annals of Internal Medicine, vol. 140, no. 2, pp. 112–120, 2004. View at Google Scholar